Objective: The efficacy of selective shunting during carotid endarterectomy (CEA) using intraoperative monitoring (IOM) for detection of cerebral ischemia is well established. There is mounting evidence that monitoring of both electroencephalography (EEG) and somatosensory evoked potentials (SSEPs) increases the sensitivity of cerebral ischemia detection. Predictors of cerebral ischemia requiring selective shunt placement using IOM of both EEG and SSEPs have not been previously identified.
The efficacy of carotid endarterectomy (CEA) for stroke risk reduction has been established through landmark randomized trials on both symptomatic and asymptomatic patients. 1 Surgical risks are low and have continued to decline over time. 2, 3 However, intraoperative cerebral ischemia remains an ongoing concern during this operation. Many surgeons treat intraoperative cerebral ischemia, when detected, with selective carotid shunt placement. The efficacy of selective shunting during CEA using intraoperative monitoring (IOM) for detection of cerebral ischemia is well established. 4 Shunting, however, is not without its own set of risks; embolization, dissection, and stroke are all known consequences. 5 Thus, the most accurate method of cerebral ischemia detection in the nonawake patient is desirable to minimize unnecessary shunt placement. There is mounting evidence that monitoring with both electroencephalography (EEG) and somatosensory evoked potentials (SSEPs) increases the sensitivity and specificity of cerebral ischemia detection. 6, 7 We have previously reported a maximum sensitivity obtained with multimodality monitoring with an IOM change in either EEG or SSEPs of 50.00% (95% confidence interval, 30.66-69.34) and specificity of simultaneous EEG and SSEP changes of 93.95% (95% confidence interval, 92. 28-95.35 ). 7 Such dual-modality IOM has increased the ability to detect cerebral hypoperfusion and to predict perioperative stroke. 8 Predictors of dual neurophysiologic IOM changes using these modalities that require shunt placement have not been previously identified. We reviewed our experience with monitoring of both SSEPs and EEG to identify the rate of selective shunt placement with this monitoring strategy. In addition, we sought to identify predictors of cerebral ischemia under dual monitoring of SSEPs and EEG to characterize patients at risk of intraoperative cerebral ischemia. Whereas previous research has shown possible predictors for cerebral ischemia to include such factors as circle of Willis anatomy and angiographic criteria, we have chosen to focus on the predictive value of more easily available clinical data points. Based on previous studies looking at risk factors of intraluminal shunt placement, we hypothesized that a number of clinical factors, including severe contralateral carotid disease, degree of ipsilateral carotid stenosis, symptomatic disease, age, diabetes, sex, and antihypertensive medication, would be possible risk factors for IOM changes. Identification of patients with increased chances of requiring shunt placement could help the surgical team anticipate neuromonitoring changes, prepare for intraluminal shunting, and decrease anxiety during the procedure.
METHODS
Study design. The Institutional Review Board at the University of Pittsburgh approved this study protocol. Informed consent was not required for this retrospective review. Consecutive individuals who underwent CEA by the Division of Vascular Surgery at the University of Pittsburgh between January 1, 2000, and December 31, 2010, were identified by the Current Procedural Terminology code 35301. The records were reviewed for demographics, baseline risk factors, medications, carotid duplex ultrasound studies, operative indications, and intraprocedural data including shunt placement and IOM changes. Additional imaging, such as computed tomography angiography and magnetic resonance angiography, was not included because these are available for only a small minority of patients and would not constitute a readily available clinical predictor. Patients were included if they had undergone CEA under dual-modality (SSEPs and EEG) neurophysiologic monitoring with plans for selective shunt placement as needed. Patients who underwent concomitant cerebrovascular procedures (eg, carotid to subclavian bypass) or concomitant coronary artery bypass grafting were excluded from the study.
Definitions. All baseline risk factors were recorded on the basis of established diagnoses identified in the medical records. Preoperative parameters of interest included age, sex, carotid ultrasound results bilaterally, and history of any of the following: hypertension, diabetes mellitus, chronic renal insufficiency, smoking, coronary artery disease, and congestive heart failure. Chronic renal insufficiency was defined as serum creatinine concentration consistently >1.5 mg/dL. Preoperative medications were also documented. Symptomatic carotid stenosis was defined as a preprocedural ipsilateral ischemic stroke or transient ischemic attack occurring in the 6 months before operation. 9 The primary outcomes were changes of SSEPs or EEG during any time of the operation, changes of SSEPs or EEG at the time of clamp placement, and shunt placement.
CEA. CEA was performed under general anesthesia in all cases. Closure technique (primary, patch, or eversion) was variable and based on the physician's preference. CEAs performed by surgeons who practice routine shunt placement were not included as these shunts were not placed on the basis of cerebral ischemia or preoperative characteristics of the patient. A clamp test of 1 minute was performed for each patient, after which the monitoring neurophysiologist alerted the surgeon of the absence of significant IOM changes. Recommendation: This study suggests that changes in electroencephalography and somatosensory evoked potential monitoring are increased in patients with a contralateral carotid occlusion, symptomatic stenosis, diabetes, and female sex. using electrodes placed on the scalp according to the International 10-20 system. EEG was recorded from these eight channels: F3-P3, P3-O1, F3-T3, T3-O1, F4-P4, P4-O2, F4-T4, and T4-O2. The 60-Hz notch filter was used and bandpass filtering set from 1 to 70 Hz. Sensitivity varied between 5 and 7 mV/div, and a time base of 30 mm/s was used. For generation of SSEPs, the left and right median or ulnar nerves were independently stimulated at the wrist using subdermal needle electrode pairs. For recording of SSEPs, scalp electrodes were placed at P4-Fz and P3-Fz (according to the International 10-20 system) to record the thalamocortical and cortical SSEPs (N20-P30), an electrode was localized on the mastoid and referenced to Fz to record the subcortical brainstem SSEPs (N13 generated at the dorsal column nucleus), and electrodes were placed at the bilateral Erb point referenced to one another to record the peripheral nerve SSEPs generated in the brachial plexus. Constant current stimulation at intensities sufficient to evoke a consistent and supramaximal peripheral nerve response was used for generation of SSEPs. Stimulation frequency was set at 3.43 Hz with a pulse duration of 0.2 millisecond. Bandpass filters were set at 10 to 300 Hz with a gain of 20k for cortical recordings and 30 Hz to 1 kHz with a gain of 50k for brainstem recordings and Erb point recordings. Averages were computed from at least 128 trials.
Significant SSEP changes were defined as a persistent and consistent prolongation of latency of 10% or 50% decrease in the amplitude in more than two consecutive averaged trials. 6 Significant EEG changes were defined as a decrease in the amplitude of fast frequency by >50% or increase in theta or delta activity by >50%. 10 IOM changes were classified as occurring anytime during the operation or as clamp-induced changes, which were defined as changes occurring during the first 5 minutes of carotid cross-clamping.
Statistical analysis. Patients were divided in two groups, those with and those without IOM changes. Those with IOM changes were further divided into those with clamp-induced changes and those with changes at other time points during the operation (Fig 1) . Analyses were completed both for patients with IOM changes at any time of the operation (Box 2 in Fig 1) and for patients with clamp-induced IOM changes (Box 4 in Fig 1) . 11 For the purpose of this study, clamp-induced changes were defined as changes occurring within 5 minutes of internal carotid artery (ICA) clamp placement. 
RESULTS
A total of 804 CEAs in 758 patients (mean age, 70.6 6 9.5 years; 59.8% male; 39.2% symptomatic) fulfilled criteria for inclusion in this study. This represented approximately 50% of CEAs done at our institution during the study period. Baseline characteristics, including rates of bilateral disease, statin use, and antiplatelet use, were similar between groups, except for female sex, symptomatic disease, and contralateral disease being more frequent in the group with the IOM changes (Table I) . Nineteen surgeons performed the CEAs included in this period.
There were 107 patients (13.6%) who had significant SSEP or EEG changes within 5 minutes of carotid clamping, whereas considerably more patients (218 [27.1%]) had SSEP or EEG changes recorded at any point during the procedure. Of the 107 patients with clamp-related SSEP or EEG changes, 90 (84.1% [11.4% overall]) received a shunt. No patients who had IOM changes outside of 5 minutes after cross-clamp placement received a shunt. The reasons for no shunt placement in the setting of significant IOM changes after carotid clamping are summarized in Table II . Technical failure was recorded when the surgeon noted an inability to pass a shunt. This occurred twice. In both instances, the surgeon stopped because of concern for dissection or arterial injury. Normalization of SSEPs or EEG with increased blood pressure was the most common reason for not shunting in this setting. There was no difference in shunt placement by closure technique (primary vs eversion vs patch; P ¼ .2).
The postoperative stroke rate, within 30 days of CEA, was 1.4% overall. Of these patients, 45% had received Predictors of IOM changes. The following were examined as potentially significant predictors of IOM changes at any time during the operation, including those not associated with ICA clamp placement (Table III) .46 ), but this did not reach statistical significance. The marginal effects, or the measure of the instantaneous effect of each explanatory variable on the predicted probability of clamp-related IOM changes, were also calculated. The presence of a contralateral ICA occlusion had the most significant impact on the probability of clamp-related IOM changes, increasing the probability of clamp-related IOM changes by 14% when present. The relative effect of diabetes and symptomatic disease on clamp-related IOM changes was similar, increasing the risk by 6% and 7%, respectively. The reported marginal effects illustrate the percentage increased risk with each additional risk factor.
Notably, whereas beta-blocker medication was a significant predictor of IOM changes at any time during the operation, this did not remain a predictor for clamprelated IOM changes as illustrated in Table IV . Patients taking beta blockers are more likely to experience IOM changes at some time during the operation (P ¼ .04) but no more likely to experience clamp-related changes specifically (P ¼ .9; Fig 2) .
In addition, risk of intraoperative SSEP or EEG changes with ICA clamp placement increased in patients with more severe degrees of contralateral ICA stenosis (P ¼ .02; Fig 3) . Similarly, the incidence of shunt placement correlated also with increasing degree of contralateral disease (P ¼ .01). Only 12.5% of patients with <50% contralateral stenosis experienced clamp-related IOM changes and 10.2% were shunted, whereas 25.6% of patients with a contralateral occlusion had significant clamp-related IOM changes (23.2% were shunted).
DISCUSSION
CEA has been shown to reduce the risk of stroke in appropriate patients with symptomatic and asymptomatic carotid artery stenosis. [12] [13] [14] [15] [16] [17] Both routine shunting and selective shunting with intraoperative cerebral cortical activity monitoring are acceptable surgical strategies; however, CEA without a shunt may allow better visualization of plaque end point and minimize exposure to shunt-related risks, which include carotid dissection, embolization, and even carotid rupture. 4, 5, 18, 19 Surgeons who practice selective shunting must employ some method of cerebral ischemia detection, such as carotid stump pressure, transcranial Doppler ultrasound, EEG, SSEPs, or cervical block anesthesia with awake monitoring, to identify patients who require carotid shunt placement. 4 There is strong evidence in support of intraoperative neurophysiologic monitoring using both SSEPs and EEG as the most sensitive method; however, predictors of neurophysiologic changes requiring shunt placement with use of this monitoring strategy have not been previously identified.
8,20 Of note, a sizable proportion of patients, 27% of patients in our series, experience IOM changes during the course of surgery. Less than half of these were at the time of carotid clamp placement. This is likely due to the increased sensitivity of this method of cerebral monitoring. We identified several predictors of these overall IOM changes, including symptomatic disease, female sex, and beta-blocker prescription.
Only 13.6% of patients had clamp-related IOM changes, and 11.4% received a shunt. This shunt rate is consistent with published figures. 4 Predictors of clamp-related IOM changes specifically included contralateral ICA occlusion, symptomatic disease, and diabetes. In patients with clamp-related changes, a small but not insignificant percentage (7.5%) resolved abnormal findings with blood pressure elevation alone. Given the known risks associated with shunt-placement, it is important for the practitioner to remember this in approaching patients with signs of intraoperative cerebral ischemia. [21] [22] [23] Notably, beta-blocker prescription was a predictor of IOM changes during the operation but not during clamp placement. This has been previously noted in the literature. 24 One explanation for this could be that use of beta-blocker medication might be related to intraoperative hypotension resulting in a degree of cerebral ischemia, although that would not be expected to be specific to beta-blocker medications. Because of the retrospective nature of this study, we could not practically access intraoperative hemodynamic information, which has not always been a part of the electronic medical record. However, Florea et al, who identified this association previously, did carefully examine intraoperative hemodynamics and found no association with beta-blocker use. 24 They proposed impaired cerebral blood flow autoregulation due to blockade of b 2 -adrenergic receptors as another potential mechanism for intraoperative ischemia related to beta blockers. 24 Sex is an important and under-recognized risk factor for intraoperative IOM changes and may also be associated with clamp-related changes specifically (although this did not reach statistical significance, P ¼ .08). Whereas female sex has previously been identified, little speculation has been made about the reason for this finding. 25 Possible explanations include smaller vasculature, more challenging anatomy, and even unique plaque characteristics. 26 Women have been noted to have higher rates of stroke after CEA for symptomatic disease, lower benefit from surgery in asymptomatic disease, and higher rates of postoperative hematoma and cranial nerve palsy. [27] [28] [29] [30] Intraoperative IOM changes and a trend toward increased need for shunt placement can be added to the list of unique and poorly understood risks for female patients. To our knowledge, diabetes has not previously been identified as a risk factor for cerebral ischemia during carotid cross-clamping, although diabetics have been previously identified as a high-risk subset of CEA patients. 31 Possible explanations for this finding include increased incidence of unstable plaque (increasing the risk of embolization) and increased intracranial atherosclerosis burden (which may affect collateral flow during carotid cross-clamping). 32, 33 Contralateral ICA disease has been most consistently identified as a predictor of cerebral ischemia requiring shunt placement during CEA. 5, 25, 34 We have shown a direct association between severity of contralateral ICA disease and risk of ipsilateral shunt placement. The rate of shunt placement for patients with contralateral carotid occlusion in our series, 23%, was consistent with reported rates in the literature. 35 However, in our series and others, the majority of patients with significant contralateral disease or contralateral occlusion will not experience IOM changes or require shunt placement. This certainly does not support a routine shunting strategy in these patients as the majority can still safely avoid shunt placement. A number of preoperative testing strategies to predict risk of cerebral ischemia and shunt placement have been identified. Some, such as status of the circle of Willis, bilateral vertebral artery stenosis, and other angiographic factors, [36] [37] [38] are not routinely collected preoperative data points. There is no evidence that increased Patients with beta-blocker prescription are more likely to experience intraoperative monitoring (IOM) changes during the operation (P ¼ .04) but no more likely to experience clamp-related changes specifically (P ¼ .9). *Denotes statistically significant difference (P < .05) in IOM changes by beta-blocker prescription. testing to identify these risk factors is cost-effective or changes outcomes. 36 However, the knowledge of the presence or absence of the risk factors identified in our analysis is easily attainable and can be used to anticipate an increased chance of clamp-related cerebral ischemia and allows the surgeon to plan as such. Patients with symptomatic disease, diabetes, and contralateral occlusions should be expected to be at increased risk of clamp-related IOM changes. Women are at increased risk of IOM changes at any time during the operation and potentially also with carotid cross-clamping. Patients taking beta blockers are also anticipated to have IOM changes, although not specifically at the time of carotid cross-clamping. For surgeons, anticipation of an increased risk of cerebral ischemia that would require carotid shunting is useful in operative preparation. We believe this is the most appropriate way to use these data for the surgeon who practices selective shunting. Despite previous attempts to create risk indices for shunt or even the use of artificial neural networks, models have generally been more accurate in predicting the lack of a need for shunt than the need for shunt. 25, 39 However, the lack of an accurate model may not be terribly important. From a clinical perspective, not only the identification of risk factors but also the enumeration of the relative consequences of their presence can inform formulation of an appropriate operative plan. We have identified the marginal effects of various risk factors. The presence of a contralateral occlusion increases the probability of shunt significantly, by 14%, whereas other risk factors have more modest effects: 6% for diabetes and 7% for symptomatic disease. The results of our study need to be interpreted with caution because of several limitations. This is a retrospective study, and risk factors were determined from record reviews and chart diagnoses. Moreover, medication use is subject to the patient's adherence, which was not captured in these data. Nonetheless, we identified comorbidities placing patients at increased risk of intraoperative cerebral ischemia consistent with contemporary literature, identified diabetes as a previously unidentified risk factor, and differentiated between risks for overall IOM changes and those associated with carotid cross-clamping specifically.
CONCLUSIONS
Although some patients can be expected to experience IOM changes with use of dual SSEP and EEG monitoring, a much smaller percentage will require carotid shunt. Patients with a contralateral carotid occlusion, symptomatic stenosis, and diabetes are at increased risk of experiencing clamp-induced IOM changes, with contralateral ICA status having the most predictive weight. Patients receiving beta blockers and female patients are more likely to experience IOM changes during the operation that are not specific to carotid clamping and may or may not be resolved with appropriate blood pressure management. 
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